Adequate Selection Of Fluoropyrimidines For Colorectal Cancer
Proceedings of the 10th Congress of Asian Federation of Coloproctology: Controversies in Colorectal Surgery(2005)
摘要
Ninety-four colorectal cancer patients underwent the surgical therapy and the activity of TS and the expression of DPD in their tumor tissue were measured. Their prognosis was compared with the contents of the enzymes and the used fluoropyrimidines. The patients received LV+5-FU and DPD inhibitory fluoropyrimidines (DIF) tended to have better prognosis than the patients receiving other type of fluoropyrimidines. The prognosis of the patients with low TS activity tended to be better than that of high TS patients. However, in the patients receiving LV+5-FU there was no difference between the two groups. The prognosis of the patients with low DPD activity was not influenced by the kinds of fluoropyrimidines. However, the prognosis of the patients receiving DIF was better than that of the patients receiving LV+5-FU (p=0.03). Therefore, the method of drug selection considering the enzymes relating fluoropyrimidines was useful for the adjuvant chemotherapy after the resection of colorectal cancer.
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要